J. Alan Crunkleton
Geschäftsführer bei MateraCor, Inc.
Profil
J.
Alan Crunkleton is currently the Chief Operating Officer at MateraCor, Inc. He previously worked as the President, Chief Executive Officer & Director at Correx, Inc. and as the President & Chief Executive Officer at Northridge Tri-Modality Imaging, Inc. He holds graduate and doctorate degrees from the Massachusetts Institute of Technology and a doctorate degree from the University of Massachusetts.
Aktive Positionen von J. Alan Crunkleton
| Unternehmen | Position | Beginn |
|---|---|---|
MateraCor, Inc.
 MateraCor, Inc. Medical SpecialtiesHealth Technology Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022. | Geschäftsführer | - |
Ehemalige bekannte Positionen von J. Alan Crunkleton
| Unternehmen | Position | Ende |
|---|---|---|
Correx, Inc.
 Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Vorstandsvorsitzender | 01.03.2014 |
Northridge Tri-Modality Imaging, Inc.
 Northridge Tri-Modality Imaging, Inc. Medical SpecialtiesHealth Technology Northridge Tri-Modality Imaging, Inc. develops and manufactures multi-modality imaging systems used in pre-clinical research. It offers tri-modality imaging, PET imaging, SPECT imaging, CT imaging, and optical imaging. The company was founded in 2001 and is headquartered in Chatsworth, CA. | Vorstandsvorsitzender | - |
Ausbildung von J. Alan Crunkleton
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Massachusetts | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Correx, Inc.
Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Health Technology |
Northridge Tri-Modality Imaging, Inc.
Northridge Tri-Modality Imaging, Inc. Medical SpecialtiesHealth Technology Northridge Tri-Modality Imaging, Inc. develops and manufactures multi-modality imaging systems used in pre-clinical research. It offers tri-modality imaging, PET imaging, SPECT imaging, CT imaging, and optical imaging. The company was founded in 2001 and is headquartered in Chatsworth, CA. | Health Technology |
MateraCor, Inc.
MateraCor, Inc. Medical SpecialtiesHealth Technology Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022. | Health Technology |
